Tracey D Rae

Title: Innovations by Tracey D Rae: A Pioneer in Biochemical Research

Introduction

Tracey D Rae is a notable inventor based in Glenview, Illinois, who has made significant contributions to the field of biochemistry through her innovative patents. With a robust background in research and development, Tracey has successfully secured two patents that focus on enhancing the understanding and application of specific proteins and their isoforms.

Latest Patents

Tracey D Rae's latest patents showcase her commitment to advancing scientific knowledge. One of her key inventions involves the Neutrophil Gelatinase-Associated Lipocalin (NGAL) protein isoforms. This patent details a composition comprising NGAL enriched from urine and recombinant Chinese hamster ovary (CHO) cells. The invention emphasizes the importance of molecular weight and isoelectric points of various NGAL isoforms, providing methods for enriching and analyzing these proteins without separating them based on charge. Her other patent focuses on alkylated interleukin-18 (IL-18), involving compositions, kits, and methods of use that highlight the versatility of IL-18 in therapeutic applications.

Career Highlights

Tracey currently works with Abbott Laboratories Corporation, a leader in the field of healthcare and pharmaceuticals. Her role combines her expertise in biochemistry with practical applications to develop groundbreaking solutions that can lead to improved health outcomes. Through research and patents, she has positioned herself as an influential figure in the scientific community.

Collaborations

Her collaborative efforts with colleagues such as Salman Ali and Ryan M Bonn further amplify her innovative journey. Together, they work on various projects that leverage their collective expertise in biochemical research, ensuring a collaborative environment that fosters creativity and scientific advancement.

Conclusion

Tracey D Rae exemplifies the spirit of innovation in the field of biochemistry. Her patents not only shed light on the complexities of protein isoforms but also underscore her capability as an inventor dedicated to making tangible impacts in healthcare. As she continues to work at Abbott Laboratories Corporation, her contributions are set to pave the way for future innovations in biochemistry.